Erken Menopoz Makale Özetleri

Haziran 2020 Makale Özetleri

  1. Ovarian tissue cryopreservation and transplantation prevents iatrogenic premature ovarian insufficiency: first 10 cases in China.Ruan X, Cheng J, Korell M, Du J, Kong W, Lu D, Wu Y, Li Y, Jin F, Gu M, Duan W, Dai Y, Yin C, Yan S, Mueck AO. Climacteric. 2020 Jun 8:1-7. doi: 10.1080/13697137.2020.1767569. Online ahead of print.
  2. Reactivating Ovarian Function through Autologous Platelet-Rich Plasma Intraovarian Infusion: Pilot Data on Premature Ovarian Insufficiency, Perimenopausal, Menopausal, and Poor Responder Women.Sfakianoudis K, Simopoulou M, Grigoriadis S, Pantou A, Tsioulou P, Maziotis E, Rapani A, Giannelou P, Nitsos N, Kokkali G, Koutsilieris M, Pantos K.J Clin Med. 2020 Jun 10;9(6):E1809. doi: 10.3390/jcm9061809.
  3. Relationship and sexual experiences in women with early onset oestrogen deficiency: comparison between women with Turner syndrome and premature ovarian insufficiency.
    Cardona Attard C, Cameron-Pimblett A, Puri D, La Rosa C, Talaulikar VS, Davies MC, Learner HI, Liao LM, Conway GS. Clin Endocrinol (Oxf). 2020 Jun 24. doi: 10.1111/cen.14271. Online ahead of print.
  4. Dysregulated cytokine profile associated with biochemical premature ovarian insufficiency.Liu P, Zhang X, Hu J, Cui L, Zhao S, Jiao X, Qin Y. Am J Reprod Immunol. 2020 Jun 21:e13292. doi: 10.1111/aji.13292. Online ahead of print.
  5. Mediatory role of abdominal obesity in the association of early menopause with diabetes among middle-aged and older Chinese women.Li Y, Zheng H, Tian L, Jia C.
    Menopause. 2020 Jun 1. doi: 10.1097/GME.0000000000001573. Online ahead of print.
  6. Recovery of ovarian function by human embryonic stem cell-derived mesenchymal stem cells in cisplatin-induced premature ovarian failure in mice.Yoon SY, Yoon JA, Park M, Shin EY, Jung S, Lee JE, Eum JH, Song H, Lee DR, Lee WS, Lyu SW.Stem Cell Res Ther. 2020 Jun 26;11(1):255. doi: 10.1186/s13287-020-01769-6.
  7. Comparative study of assisted reproductive outcomes between young patients with occult premature ovarian insufficiency and advanced-age patients.Yao LN, Lin WQ, Jiang N, Li C, Cao HF, Li H, Qian JH.J Int Med Res. 2020 Jun;48(6):300060520934656. doi: 10.1177/0300060520934656.
  8. A comparison of the effects of Chinese non-pharmaceutical therapies for premature ovarian failure: A PRISMA-compliant systematic review and network meta-analysis.Zhang J, Huang X, Liu Y, He Y, Yu H.Medicine (Baltimore). 2020 Jun 26;99(26):e20958. doi: 10.1097/MD.0000000000020958.
  9. Evaluation of CD4+CD25+FOXP3+regulatory T cells and FOXP3 mRNA in premature ovarian insufficiency.Xiong J, Tan R, Wang W, Wang H, Pu D, Wu J.Climacteric. 2020 Jun;23(3):267-272. doi: 10.1080/13697137.2019.1703938. Epub 2020 Jan 15.
  10. Bone mass in women with premature ovarian insufficiency: a comparative study between hormone therapy and combined oral contraceptives.Gazarra LBC, Bonacordi CL, Yela DA, Benetti-Pinto CL.Menopause. 2020 Jun 22. doi: 10.1097/GME.0000000000001592. Online ahead of print.
  11. Being born preterm or with low weight implies a risk of infertility and premature loss of ovarian function; a national register study.Sydsjö G, Bladh M, Rindeborn K, Hammar M, Rodriguez-Martinez H, Nedstrand E.Ups J Med Sci. 2020 Jun 12:1-5. doi: 10.1080/03009734.2020.1770380. Online ahead of print.
  12. An explanation of the mechanisms underlying fragile X-associated premature ovarian insufficiency.Rose BI, Brown SE.J Assist Reprod Genet. 2020 Jun;37(6):1313-1322. doi: 10.1007/s10815-020-01774-x. Epub 2020 May 6.
  13. Mapping premature ovarian insufficiency and potential environmental factors: A tool for triggering in-depth research of the problem in Slovenia.Geršak ŽM, Geršak K, Rejc T, Perharič L, Zaletel-Kragelj L, Kukec A.Geospat Health. 2020 Jun 17;15(1). doi: 10.4081/gh.2020.800.
  14. ‘My relationships have changed because I’ve changed’: biographical disruption, personal relationships and the formation of an early menopausal subjectivity.Johnston-Ataata K, Flore J, Kokanović R, Hickey M, Teede H, Boyle JA, Vincent A.Sociol Health Illn. 2020 Jun 25. doi: 10.1111/1467-9566.13143. Online ahead of print.
  15. Recent trends in stem cell therapy for premature ovarian insufficiency and its therapeutic potential: a review.Na J, Kim GJ.J Ovarian Res. 2020 Jun 23;13(1):74. doi: 10.1186/s13048-020-00671-2.
  16. POI after chemotherapy and bone marrow transplant may mimic disorders of sexual differentiation – a case report of a patient with primary amenorrhea and 46, XY karyotype.Kruszewska J, Krzywdzińska S, Grymowicz M, Smolarczyk R, Meczekalski B.Gynecol Endocrinol. 2020 Jun;36(6):564-566. doi: 10.1080/09513590.2019.1703941. Epub 2019 Dec 20.

Mayıs 2020 Makale Özetleri

  1. Premature ovarian failure and tissue engineering.Ghahremani-Nasab M, Ghanbari E, Jahanbani Y, Mehdizadeh A, Yousefi M.J Cell Physiol. 2020 May;235(5):4217-4226. doi: 10.1002/jcp.29376. Epub 2019 Oct 29.
  2. Early menopause is associated with increased risk of arterial hypertension: A systematic review and meta-analysis.Anagnostis P, Theocharis P, Lallas K, Konstantis G, Mastrogiannis K, Bosdou JK, Lambrinoudaki I, Stevenson JC, Goulis DG.Maturitas. 2020 May;135:74-79. doi: 10.1016/j.maturitas.2020.03.006. Epub 2020 Mar 17.
  3. Premature ovarian failure in patients affected by systemic lupus erythematosus: a cross-sectional study. Ceccarelli F, Orefice V, Perrone G, Pirone C, Perricone C, Truglia S, Miranda F, Pacucci VA, Spinelli FR, Galoppi P, Alessandri C, Valesini G, Conti F.Clin Exp Rheumatol. 2020 May-Jun;38(3):450-454. Epub 2020 Feb 14.
  4. FANCL gene mutations in premature ovarian insufficiency.Yang Y, Guo T, Liu R, Ke H, Xu W, Zhao S, Qin Y.Hum Mutat. 2020 May;41(5):1033-1041. doi: 10.1002/humu.23997. Epub 2020 Feb 24.
  5. Long noncoding RNA HCP5 participates in premature ovarian insufficiency by transcriptionally regulating MSH5 and DNA damage repair via YB1.Wang X, Zhang X, Dang Y, Li D, Lu G, Chan WY, Leung PCK, Zhao S, Qin Y, Chen ZJ.Nucleic Acids Res. 2020 May 7;48(8):4480-4491. doi: 10.1093/nar/gkaa127.
  6. Exosomal miRNA-17-5p derived from human umbilical cord mesenchymal stem cells improves ovarian function in premature ovarian insufficiency by regulating SIRT7.Ding C, Zhu L, Shen H, Lu J, Zou Q, Huang C, Li H, Huang B.Stem Cells. 2020 May 22. doi: 10.1002/stem.3204. Online ahead of print.
  7. Primary ovarian insufficiency, meiosis and DNA repair.Veitia RA.Biomed J. 2020 May 4:S2319-4170(20)30031-7. doi: 10.1016/j.bj.2020.03.005.
  8. Interferential current: a new option for the treatment of sexual complaints in women with premature ovarian insufficiency using systemic hormone therapy: a randomized clinical trial. Benetti-Pinto CL, Giraldo HP, Giraldo AE, Mira TA, Yela DA.Menopause. 2020 May;27(5):519-525. doi: 10.1097/GME.0000000000001501.
  9. An explanation of the mechanisms underlying fragile X-associated premature ovarian insufficiency.Rose BI, Brown SE.J Assist Reprod Genet. 2020 May 6. doi: 10.1007/s10815-020-01774-x.
  10. Novel phenotype of syndromic premature ovarian insufficiency associated with TP63 molecular defect.Mathorne SW, Ravn P, Hansen D, Beck-Nielsen SS, Gjørup H, Sørensen KP, Fagerberg CR.Clin Genet. 2020 May;97(5):779-784. doi: 10.1111/cge.13725. Epub 2020 Feb 24.

Nisan 2020 Makale Özetleri

  1. Premature Menopause and Risk for Cardiovascular Disease-Reply.Honigberg MC, Natarajan P. JAMA. 2020 Apr 28;323(16):1617-1618. doi: 10.1001/jama.2020.2536. PMID: 32343325
  2. Premature Menopause and Risk for Cardiovascular Disease.Scarabin PY. JAMA. 2020 Apr 28;323(16):1616. doi: 10.1001/jama.2020.2533. PMID: 32343323
  3. The management of gynecological complications in long-term survivors after allogeneic hematopoietic cell transplantation-a single-center real-life experience.Klasa Ł, Sadowska-Klasa A, Piekarska A, Wydra D, Zaucha JM. Ann Hematol. 2020 Apr 28. doi: 10.1007/s00277-020-04034-1. PMID: 32342133
  4. Estrogen regulation of germline stem cell differentiation as a mechanism contributing to female reproductive aging.Satirapod C, Wang N, MacDonald JA, Sun M, Woods DC, Tilly JL. Aging (Albany NY). 2020 Apr 17;12. doi: 10.18632/aging.103080. PMID: 32302290
  5. Trends of Premature and Early Menopause: a Comparative Study of the US National Health and Nutrition Examination Survey and the Korea National Health and Nutrition Examination Survey.Choe SA, Sung J. J Korean Med Sci. 2020 Apr 13;35(14):e97. doi: 10.3346/jkms.2020.35.e97. PMID: 32281314
  6. Mutation in ALOX12B likely cause of POI and also ichthyosis in a large Iranian pedigree.Alavi A, Darki F, Bidgoli MMR, Zare-Abdollahi D, Moini A, Shahshahani MM, Fischer J, Elahi E. Mol Genet Genomics. 2020 Apr 6. doi: 10.1007/s00438-020-01663-z. PMID: 32253496 Similar articles
  7. Early menopause is associated with increased risk of arterial hypertension: A systematic review and meta-analysis.Anagnostis P, Theocharis P, Lallas K, Konstantis G, Mastrogiannis K, Bosdou JK, Lambrinoudaki I, Stevenson JC, Goulis DG. Maturitas. 2020 May;135:74-79. doi: 10.1016/j.maturitas.2020.03.006. Epub 2020 Mar 17. Review. PMID: 32252968
  8. A prospective study of inflammatory biomarker levels and risk of early menopause.Bertone-Johnson ER, Manson JE, Purdue-Smithe AC, Hankinson SE, Rosner BA, Whitcomb BW. Menopause. 2019 Jan;26(1):32-38. doi: 10.1097/GME.0000000000001162. PMID: 29994968
  9. Serum androgen profiles in women with premature ovarian insufficiency: a systematic review and meta-analysis.Soman M, Huang LC, Cai WH, Xu JB, Chen JY, He RK, Ruan HC, Xu XR, Qian ZD, Zhu XM. Menopause. 2019 Jan;26(1):78-93. doi: 10.1097/GME.0000000000001161. PMID: 29994966

Mart 2020 Makale Özetleri

  1. Demographic, clinical and hormonal characteristics of patients with premature ovarian insufficiency and those of early menopause: data from two tertiary premature ovarian insufficiency centers in Greece. Bompoula MS, Valsamakis G, Neofytou S, Messaropoulos P, Salakos N, Mastorakos G, Kalantaridou SN. Gynecol Endocrinol. 2020 Mar 25:1-5. doi: 10.1080/09513590.2020.1739266. [Epub ahead of print]
  2. A critical analysis of the impact of endocrine disruptors as a possible etiology of primary ovarian insufficiency. Monteiro CS, Xavier EBS, Caetano JPJ, Marinho RM. JBRA Assist Reprod. 2020 Mar 23. doi: 10.5935/1518-0557.20200005. [Epub ahead of print] Review.
  3. Chinese herbal medicine for premature ovarian insufficiency: A protocol for systematic review.Shao Y, Zhou H, Zhou M, Ying P, Yao Z, Jiang X. Medicine (Baltimore). 2020 Mar;99(11):e19371. doi: 10.1097/MD.0000000000019371.
  4. Hormone Replacement Therapy Prescription After Premature Surgical Menopause.Garg N, Behbehani S, Kosiorek H, Wasson M. J Minim Invasive Gynecol. 2020 Mar 12. pii: S1553-4650(20)30124-2. doi: 10.1016/j.jmig.2020.03.002.
  5. Pelvic floor disorders in women with premature ovarian insufficiency: a cross-sectional study.Fante JF, Machado HDC, Juliato CRT, Benetti-Pinto CL, Brito LGO. Menopause. 2020 Apr;27(4):450-458. doi: 10.1097/GME.0000000000001523.
  6. Novel pathogenic mutations in minichromosome maintenance complex component 9 (MCM9) responsible for premature ovarian insufficiency.Guo T, Zheng Y, Li G, Zhao S, Ma J, Qin Y. Fertil Steril. 2020 Apr;113(4):845-852. doi: 10.1016/j.fertnstert.2019.11.015. Epub 2020 Mar 4.
  7. The cardiovascular risk profile of middle age women previously diagnosed with premature ovarian insufficiency: A case-control study.Gunning MN, Meun C, van Rijn BB, Daan NMP, Roeters van Lennep JE, Appelman Y, Boersma E, Hofstra L, Fauser CGKM, Rueda-Ochoa OL, Ikram MA, Kavousi M, Lambalk CB, Eijkemans MJC, Laven JSE, Fauser BCJM; CREW consortium. PLoS One. 2020 Mar 5;15(3):e0229576. doi: 10.1371/journal.pone.0229576. eCollection 2020.
  8. Osteoporosis and premature ovarian insufficiency: geographic variation in clinicians’ and consumers’ knowledge gaps and barriers to care.Jones AR, Goh M, Langham R, Boyle J, Milat F, Ebeling PR, Teede H, Vincent AJ. Arch Osteoporos. 2020 Mar 3;15(1):38. doi: 10.1007/s11657-020-00713-8.
  9. Women’s perspectives of early menopause: development of a word cloud.Yeganeh L, Boyle JA, Gibson-Helm M, Teede H, Vincent AJ. Climacteric. 2020 Mar 3:1-4. doi: 10.1080/13697137.2020.1730318.

Şubat 2020 Makale Özetleri

  1. Cervical cancer survivors’ attitudes and understanding of menopause and hormone therapy.Cotangco K, Class QA, Johnson TP, Kothari R. Menopause. 2020 Feb 24. doi: 10.1097/GME.0000000000001520. [Epub ahead of print] PMID: 32108734
  2. Interferential current: a new option for the treatment of sexual complaints in women with premature ovarian insufficiency using systemic hormone therapy: a randomized clinical trial.Benetti-Pinto CL, Giraldo HP, Giraldo AE, Mira TA, Yela DA. Menopause. 2020 Feb 24. doi: 10.1097/GME.0000000000001501. [Epub ahead of print] PMID: 32108732
  3. Controversies Regarding Ovarian Suppression and Infertility in Early Stage Breast Cancer.Durrani S, Heena H. Cancer Manag Res. 2020 Feb 5;12:813-817. doi: 10.2147/CMAR.S231524. eCollection 2020. Review. PMID: 32104064
  4. Long-Term Effects of Radioiodine Treatment on Female Fertility in Survivors of Childhood Differentiated Thyroid Carcinoma. Nies M, Cantineau AEP, Arts EGJM, van den Berg MH, van Leeuwen FE, Muller Kobold AC, Klein Hesselink MS, Burgerhof JGM, Brouwers AH, van Dam EWCM, Havekes B, van den Heuvel-Eibrink MM, Corssmit EPM, Kremer LCM, Netea-Maier R, van der Pal HJH, Peeters RP, Plukker JTM, Ronckers CM, van Santen HM, van der Horst-Schrivers ANA, Tissing WJE, Bocca G, van Dulmen-den Broeder E, Links TP. Thyroid. 2020 Feb 20. doi: 10.1089/thy.2019.0560. [Epub ahead of print] PMID: 32079487
  5. The Use of Sex-Specific Factors in the Assessment of Women’s Cardiovascular Risk. Agarwala A, Michos ED, Samad Z, Ballantyne CM, Virani SS. Circulation. 2020 Feb 18;141(7):592-599. doi: 10.1161/CIRCULATIONAHA.119.043429. Epub 2020 Feb 17. PMID: 32065772
  6. Menopausal symptoms in relationship to breast cancer-specific quality of life after adjuvant cytotoxic treatment in young breast cancer survivors.Yeo W, Pang E, Liem GS, Suen JJS, Ng RYW, Yip CCH, Li L, Yip CHW, Mo FKF. Health Qual Life Outcomes. 2020 Feb 10;18(1):24. doi: 10.1186/s12955-020-1283-x. PMID: 32041627
  7. Cascade Testing for Fragile X Syndrome in a Rural Setting in Cameroon (Sub-Saharan Africa).Kengne Kamga K, Nguefack S, Minka K, Wonkam Tingang E, Esterhuizen A, Nchangwi Munung S, De Vries J, Wonkam A. Genes (Basel). 2020 Jan 28;11(2). pii: E136. doi: 10.3390/genes11020136. PMID: 32012997

Ocak 2020 Makale Özetleri

  1. Health-related Quality-Of-Life Among Patients With Premature Ovarian Insufficiency: A Systematic Review and Meta-Analysis XT Li et al. Qual Life Res 29 (1), 19-36. Jan 2020. PMID 31620985. – Review
  2. Analysis of NR5A1 in 142 Patients With Premature Ovarian Insufficiency, Diminished Ovarian Reserve, or Unexplained InfertilityS Jaillard et al. Maturitas 131, 78-86. Jan 2020. PMID 31787151.
  3. Novel PMM2 Missense Mutation in a Chinese Family With Non-Syndromic Premature Ovarian Insufficiency T Peng et al. J Assist Reprod Genet. 2020. PMID 31902100.
  4. Variation Analysis of Tousled Like Kinase 1 Gene in Patients With Sporadic Premature Ovarian InsufficiencyX Xu et al. Gynecol Endocrinol 36 (1), 33-35. Jan 2020. PMID 31362519.
  5. Prevalence and Correlates of Early-Onset Menopause Among Women Living With HIV in Canada N Andany et al. Menopause 27 (1), 66-75. Jan 2020. PMID 31688411.
  6. Advances in Human Primordial Follicle Activation and Premature Ovarian Insufficiency EA Ford et al. Reproduction 159 (1), R15-R29. Jan 2020. PMID 31376814. – Review
  7. Small Extracellular Vesicles Derived From Embryonic Stem Cells Restore Ovarian Function of Premature Ovarian Failure Through PI3K/AKT Signaling PathwayM Liu et al. Stem Cell Res Ther 11 (1), 3. 2020. PMID 31900201.

Aralık 2019 Makale Özetleri

  1. Clinical and Genetic Investigation of Premature Ovarian Insufficiency Cases from Turkey.Oral E, Toksoy G, Sofiyeva N, Celik HG, Karaman B, Basaran S, Azami A, Uyguner ZO. J Gynecol Obstet Hum Reprod. 2019 Dec;48(10):817-823. doi: 10.1016/j.jogoh.2019.04.007. Epub 2019 Apr 23. PMID: 31026518
  2. Menopause guideline appraisal and algorithm development for premature ovarian insufficiency.Yeganeh L, Boyle JA, Wood A, Teede H, Vincent AJ. Maturitas. 2019 Dec;130:21-31. doi: 10.1016/j.maturitas.2019.09.009. Epub 2019 Sep 22. PMID: 31706432
  3. Fracture rate in women with oestrogen deficiency – Comparison of Turner syndrome and premature ovarian insufficiency. Cardona Attard C, Cameron-Pimblett A, Puri D, Elliot J, Wilson JC, Talaulikar VS, Davies MC, Conway GS. Clin Endocrinol (Oxf). 2019 Dec;91(6):743-749. doi: 10.1111/cen.14110. Epub 2019 Nov 6. PMID: 31612507
  4. Premature ovarian insufficiency in adolescence: a chance for early diagnosis? Michala L, Stefanaki K, Loutradis D. Hormones (Athens). 2019 Dec 11. doi: 10.1007/s42000-019-00141-5. [Epub ahead of print] Review. PMID: 31828604
  5. Rare variants in FANCA induce premature ovarian insufficiency. Yang X, Zhang X, Jiao J, Zhang F, Pan Y, Wang Q, Chen Q, Cai B, Tang S, Zhou Z, Chen S, Yin H, Fu W, Luo Y, Li D, Li G, Shang L, Yang J, Jin L, Shi Q, Wu Y. Hum Genet. 2019 Dec;138(11-12):1227-1236. doi: 10.1007/s00439-019-02059-9. Epub 2019 Sep 18. PMID: 31535215
  6. A novel EIF4ENIF1 mutation associated with a diminished ovarian reserve and premature ovarian insufficiency identified by whole-exome sequencing. Zhao M, Feng F, Chu C, Yue W, Li L. J Ovarian Res. 2019 Dec 6;12(1):119. doi: 10.1186/s13048-019-0595-0. PMID: 31810472
  7. Transcriptome analysis reveals that cyclophosphamide induces premature ovarian failure by blocking cholesterol biosynthesis pathway. Li Q, An X, Man X, Chu M, Zhao T, Yu H, Li Z. Life Sci. 2019 Dec 15;239:116999. doi: 10.1016/j.lfs.2019.116999. Epub 2019 Oct 23. PMID: 31654746

Kasım 2019 Makale Özetleri

  1. CHIWOS Research Team. Prevalence and correlates of early-onset menopause among women living with HIV in Canada.Andany N, Kaida A, de Pokomandy A, Yudin MH, Wang L, Kennedy VL, Webster K, Loutfy M; Menopause. 2019 Nov 4. doi: 10.1097/GME.0000000000001423. [Epub ahead of print] PubMed PMID: 31688411.
  2. Early menopause and risk of cardiovascular disease: an issue for young women.Bernhardt L, Lawson CA. Lancet Public Health. 2019 Nov;4(11):e539-e540. doi: 10.1016/S2468-2667(19)30184-7. Epub 2019 Oct 3. PubMed PMID: 31588030.
  3. Fracture rate in women with oestrogen deficiency – Comparison of Turner syndrome and premature ovarian insufficiency. Cardona Attard C, Cameron-Pimblett A, Puri D, Elliot J, Wilson JC, Talaulikar VS, Davies MC, Conway GS. Clin Endocrinol (Oxf). 2019 Dec;91(6):743-749. doi: 10.1111/cen.14110. Epub 2019 Nov 6. PubMed PMID: 31612507.
  4. Association between spontaneous ovulation and serum anti-Müllerian hormone levels in a premature ovarian insufficiency patient after a multimodal treatment for breast cancer.Wakimoto Y, Fukui A, Wakimoto G, Ikezawa Y, Matsuoka M, Omote M, Sugiyama Y, Ukita Y, Kato T, Shibahara H. J Obstet Gynaecol Res. 2019 Nov;45(11):2297-2301. doi: 10.1111/jog.14101. Epub 2019 Aug 27. PubMed PMID: 31456293.
  5. Effects of quercetin and rosuvastatin each alone or in combination on cyclophosphamide-induced premature ovarian failure in female albino mice. Elkady MA, Shalaby S, Fathi F, El-Mandouh S. Hum Exp Toxicol. 2019 Nov;38(11):1283-1295. doi: 10.1177/0960327119865588. Epub 2019 Aug 1. PubMed PMID: 31370695.
  6. Abnormal aggregation of myeloid-derived suppressor cells in a mouse model of cyclophosphamide-induced premature ovarian failure. Han M, Cheng H, Wang J, Yu Y, Wang F, Zhu R, Wang W, Yang S, Li H. Gynecol Endocrinol. 2019 Nov;35(11):985-990. doi: 10.1080/09513590.2019.1616173. Epub 2019 May 24. PubMed PMID: 31124382.
  7. Upregulation of FSHR and PCNA by administration of coenzyme Q10 on cyclophosphamide-induced premature ovarian failure in a mouse model. Delkhosh A, Delashoub M, Tehrani AA, Bahrami AM, Niazi V, Shoorei H, Banimohammad M, Kalarestaghi H, Shokoohi M, Agabalazadeh A, Mohaqiq M. J Biochem Mol Toxicol. 2019 Nov;33(11):e22398. doi: 10.1002/jbt.22398. Epub 2019 Sep 26. PubMed PMID: 31557371.

Ekim 2019 Makale Özetleri

  1. Reduced Foxo3a, FoxL2, and p27 mRNA expression in human ovarian tissue in premature ovarian insufficiency.Thanatsis N, Kaponis A, Koika V, Georgopoulos NA, Decavalas GO. Hormones (Athens). 2019 Oct 21. doi: 10.1007/s42000-019-00134-4.
  2. Effects of FSHR polymorphisms on premature ovarian insufficiency in human beings: a meta-analysis.Huang W, Cao Y, Shi L. Reprod Biol Endocrinol. 2019 Oct 19;17(1):80. doi: 10.1186/s12958-019-0528-1.
  3. Serum biomarker analysis in patients with premature ovarian insufficiency.Liu J, Huang X, Cao X, Feng X, Wang X. Cytokine. 2019 Oct 16;126:154876. doi: 10.1016/j.cyto.2019.154876.
  4. Health-related quality-of-life among patients with premature ovarian insufficiency: a systematic review and meta-analysis.Li XT, Li PY, Liu Y, Yang HS, He LY, Fang YG, Liu J, Liu BY, Chaplin JE. Qual Life Res. 2019 Oct 16. doi: 10.1007/s11136-019-02326-2.
  5. Induced premature ovarian insufficiency by using D galactose and its effects on reproductive profiles in small laboratory animals: a systematic review.Rostami Dovom M, Noroozzadeh M, Mosaffa N, Zadeh-Vakili A, Piryaei A, Ramezani Tehrani F. J Ovarian Res. 2019 Oct 16;12(1):96. doi: 10.1186/s13048-019-0565-6.
  6. Ovarian damage from chemotherapy and current approaches to its protection.Spears N, Lopes F, Stefansdottir A, Rossi V, De Felici M, Anderson RA, Klinger FG. Hum Reprod Update. 2019 Oct 10. pii: dmz027. doi: 10.1093/humupd/dmz027.
  7. Management of bone health in women with premature ovarian insufficiency: Systematic appraisal of clinical practice guidelines and algorithm development.Kiriakova V, Cooray SD, Yeganeh L, Somarajah G, Milat F, Vincent AJ. Maturitas. 2019 Oct;128:70-80. doi: 10.1016/j.maturitas.2019.07.021.
  8. Early menopause and risk of cardiovascular disease: an issue for young women.Bernhardt L, Lawson CA. Lancet Public Health. 2019 Oct 3. pii: S2468-2667(19)30184-7. doi: 10.1016/S2468-2667(19)30184-7.

Eylül 2019 Makale Özetleri

  1. Pregnancy following diagnosis of premature ovarian insufficiency: a systematic review.Fraison E, Crawford G, Casper G, Harris V, Ledger W. Reprod Biomed Online. 2019 Sep;39(3):467-476. doi: 10.1016/j.rbmo.2019.04.019.
  2. Sexual health and rehabilitation after ovarian suppression treatment (SHARE-OS): a clinical intervention for young breast cancer survivors.Bober SL, Fine E, Recklitis CJ. J Cancer Surviv. 2019 Sep 3. doi: 10.1007/s11764-019-00800-x.
  3. miR-15b induces premature ovarian failure in mice via inhibition of α-Klotho expression in ovarian granulosa cells.Liu T, Liu Y, Huang Y, Chen J, Yu Z, Chen C, Lai L. Free Radic Biol Med. 2019 Sep;141:383-392. doi: 10.1016/j.freeradbiomed.2019.07.010.
  4. Rare variants in FANCA induce premature ovarian insufficiency.Yang X, Zhang X, Jiao J, Zhang F, Pan Y, Wang Q, Chen Q, Cai B, Tang S, Zhou Z, Chen S, Yin H, Fu W, Luo Y, Li D, Li G, Shang L, Yang J, Jin L, Shi Q, Wu Y. Hum Genet. 2019 Sep 18. doi: 10.1007/s00439-019-02059-9.
  5. Lack of association between early menopause and non-alcoholic fatty liver disease in postmenopausal women.Park SH, Park YE, Lee J, Choi JH, Heo NY, Park J, Kim TO, Moon YS, Kim HK, Jang HJ, Park HY, Jeong CH, Suk KT, Kim DJ. Climacteric. 2019 Sep 20:1-5. doi: 10.1080/13697137.2019.1650018.
  6. Bone marrow mesenchymal stem cell-derived exosomal miR-144-5p improves rat ovarian function after chemotherapy-induced ovarian failure by targeting PTEN.Yang M, Lin L, Sha C, Li T, Zhao D, Wei H, Chen Q, Liu Y, Chen X, Xu W, Li Y, Zhu X. Lab Invest. 2019 Sep 19. doi: 10.1038/s41374-019-0321-y.
  7. Young women’s opinions on the use of a blood test to predict the possibility of premature ovarian failure: a qualitative study.Grootenhuis A, van den Hoogen A, Broekmans F, Torrance H, van Os-Medendorp H, Ockhuijsen H. Hum Fertil (Camb). 2019 Sep 18:1-11. doi: 10.1080/14647273.2019.1665198.

Ağustos 2019 Makale Özetleri

  1. Association between spontaneous ovulation and serum anti-Müllerian hormone levels in a premature ovarian insufficiency patient after a multimodal treatment for breast cancer.Wakimoto Y, Fukui A, Wakimoto G, Ikezawa Y, Matsuoka M, Omote M, Sugiyama Y, Ukita Y, Kato T, Shibahara H. J Obstet Gynaecol Res. 2019 Aug 27. doi: 10.1111/jog.14101.
  2. Premature ovarian insufficiency (POI) and autoimmunity-an update appraisal.Kirshenbaum M, Orvieto R. J Assist Reprod Genet. 2019 Aug 22. doi: 10.1007/s10815-019-01572-0.
  3. Therapeutic effects of human umbilical cord mesenchymal stem cell-derived microvesicles on premature ovarian insufficiency in mice.Yang Z, Du X, Wang C, Zhang J, Liu C, Li Y, Jiang H.
    Stem Cell Res Ther. 2019 Aug 14;10(1):250. doi: 10.1186/s13287-019-1327-5.
  4. Association of BMP15 and GDF9 variants to premature ovarian insufficiency.Santos M, Cordts EB, Peluso C, Dornas M, Neto FHV, Bianco B, Barbosa CP, Christofolini DM. J Assist Reprod Genet. 2019 Aug 7. doi: 10.1007/s10815-019-01548-0.
  5. In Utero DDT Exposure and Breast Density in Early Menopause by Maternal History of Breast Cancer.McDonald JA, Cirillo PM, Tehranifar P, Krigbaum NY, Engman N, Cohn BA, Terry MB.
    Reprod Toxicol. 2019 Aug 14. pii: S0890-6238(19)30068-1. doi: 10.1016/j.reprotox.2019.08.009.
  6. Oral oyster polypeptides protect ovary against D-galactose-induced premature ovarian failure in C57BL/6 mice. Li Y, Qiu W, Zhang Z, Han X, Bu G, Meng F, Kong F, Cao X, Huang A, Feng Z, Li Y, Zeng X, Du X. J Sci Food Agric. 2019 Aug 22. doi: 10.1002/jsfa.9997.
  7. Systems Pharmacology Uncovers Multiple Mechanisms of Erxian Decoction () for Treatment of Premature Ovarian Failure. Du B, Liu LH, Lv YJ, Ai H.
    Chin J Integr Med. 2019 Aug 5. doi: 10.1007/s11655-019-3201-9.
  8. Effects of quercetin and rosuvastatin each alone or in combination on cyclophosphamide-induced premature ovarian failure in female albino mice. Elkady MA, Shalaby S, Fathi F, El-Mandouh S.
    Hum Exp Toxicol. 2019 Aug 1:960327119865588. doi: 10.1177/0960327119865588.

Temmuz 2019 Makale Özetleri

  1. Variation analysis of tousled like kinase 1 gene in patients with sporadic premature ovarian insufficiency.Xu X, Su S, Cao Y, Zhao S, Li W, Qin Y. Gynecol Endocrinol. 2019 Jul 31:1-3. doi: 10.1080/09513590.2019.1630606.
  2. Clinical characteristics and relationship between myasthenia gravis and premature ovarian failure: report of two cases. Cao L, Liu W, Zhu Z. J Int Med Res. 2019 Jul 25:300060519863525. doi: 10.1177/0300060519863525.
  3. The effect of premature ovarian failure on inner ear function. Karaer I, Tuncay G. J Obstet Gynaecol. 2019 Jul 25:1-5. doi: 10.1080/01443615.2019.1621815
  4. Resveratrol Plays a Protective Role against Premature Ovarian Failure and Prompts Female Germline Stem Cell Survival. Jiang Y, Zhang Z, Cha L, Li L, Zhu D, Fang Z, He Z, Huang J, Pan Z.
    Int J Mol Sci. 2019 Jul 23;20(14). pii: E3605. doi: 10.3390/ijms20143605.
  5. The effects of human umbilical cord-derived mesenchymal stem cell transplantation on endometrial receptivity are associated with Th1/Th2 balance change and uNK cell expression of uterine in autoimmune premature ovarian failure mice. Lu X, Cui J, Cui L, Luo Q, Cao Q, Yuan W, Zhang H. Stem Cell Res Ther. 2019 Jul 22;10(1):214. doi: 10.1186/s13287-019-1313-y.
  6. Icariin exerts a protective effect against d-galactose induced premature ovarian failure via promoting DNA damage repair. Li N, Wang J, Wang X, Sun J, Li Z. Biomed Pharmacother. 2019 Jul 19;118:109218. doi: 10.1016/j.biopha.2019.109218.
  7. Effect of transcutaneous electrical acupoint stimulation on protecting against radiotherapy- induced ovarian damage in mice. Tan R, He Y, Zhang S, Pu D, Wu J. J Ovarian Res. 2019 Jul 19;12(1):65. doi: 10.1186/s13048-019-0541-1.
  8. Menstrual blood derived mesenchymal stem cells combined with Bushen Tiaochong recipe improved chemotherapy-induced premature ovarian failure in mice by inhibiting GADD45b expression in the cell cycle pathway. Guo F, Xia T, Zhang Y, Ma X, Yan Z, Hao S, Han Y, Ma R, Zhou Y, Du X. Reprod Biol Endocrinol. 2019 Jul 16;17(1):56. doi: 10.1186/s12958-019-0499-2.
  9. miR-15b induces premature ovarian failure in mice via inhibition of α-Klotho expression in ovarian granulosa cells. Liu T, Liu Y, Huang Y, Chen J, Yu Z, Chen C, Lai L. Free Radic Biol Med. 2019 Jul 13;141:383-392. doi: 10.1016/j.freeradbiomed.2019.07.010.
  10. A Case Series on Natural Conceptions Resulting in Ongoing Pregnancies in Menopausal and Prematurely Menopausal Women Following Platelet-Rich Plasma Treatment. Pantos K, Simopoulou M, Pantou A, Rapani A, Tsioulou P, Nitsos N, Syrkos S, Pappas A, Koutsilieris M, Sfakianoudis K. Cell Transplant. 2019 Jul 4:963689719859539. doi: 10.1177/0963689719859539.
  11. Sleep quality and fatigue in women with premature ovarian insufficiency receiving hormone therapy: a comparative study. Benetti-Pinto CL, Menezes C, Yela DA, Cardoso TM. Menopause. 2019 Jul 8. doi: 10.1097/GME.0000000000001379.

Haziran 2019 Makale Özetleri

  1. Time to consider ovarian tissue cryopreservation for girls with Turner’s syndrome: an opinion paper.Jeve YB, Gelbaya T, Fatum M. Hum Reprod Open. 2019 Jun 20;2019(3):hoz016. doi: 10.1093/hropen/hoz016.
  2. Protective effect of gonadotropin-releasing hormone agonist against chemotherapy-induced ovarian dysfunction: A meta-analysis.Zheng F, Zhu B, Feng Q, Wu L, Cui Y, Liu Y, Wang Y. Oncol Lett. 2019 Jun;17(6):5319-5326. doi: 10.3892/ol.2019.10252.
  3. Sexuality in premature ovarian insufficiency.Nappi RE, Cucinella L, Martini E, Rossi M, Tiranini L, Martella S, Bosoni D, Cassani C. Climacteric. 2019 Jun;22(3):289-295. doi: 10.1080/13697137.2019.1575356.
  4. Treatment potential of bone marrow-derived stem cells in women with diminished ovarianreserves and premature ovarian failure.Herraiz S, Pellicer N, Romeu M, Pellicer A. Curr Opin Obstet Gynecol. 2019 Jun;31(3):156-162. doi: 10.1097/GCO.0000000000000531.
  5. The effect of premature ovarian insufficiency on nasal mucociliary clearance time.Karaer I, Tuncay G. Gynecol Endocrinol. 2019 Jun 25:1-4. doi: 10.1080/09513590.2019.1631275.
  6. Successful achievement after heterotopic transplantations of long-term stored ovarian tissue in Hodgkin’s lymphoma survivor.Fabbri R, Seracchioli R, Vicenti R, Paradisi R, Rossi S, De Meis L, Ciccarone M, Caprara G, Martino NA, Macciocca M. Gynecol Endocrinol. 2019 Jun;35(6):470-472. doi: 10.1080/09513590.2018.1549218
  7. The effects of human menstrual blood stem cells-derived granulosa cells on ovarian follicle formation in a rat model of premature ovarian failure.Manshadi MD, Navid S, Hoshino Y, Daneshi E, Noory P, Abbasi M. Microsc Res Tech. 2019 Jun;82(6):635-642. doi: 10.1002/jemt.23120.
  8. Identifying and Addressing Osteoporosis Knowledge Gaps in Women with Premature OvarianInsufficiency and Early Menopause: A mixed methods study.Goh M, Nguyen HH, Khan NN, Milat F, Boyle JA, Vincent AJ. Clin Endocrinol (Oxf). 2019 Jun 19. doi: 10.1111/cen.14049.

Mayıs 2019 Makale Özetleri

  1. Abnormal aggregation of myeloid-derived suppressor cells in a mouse model of cyclophosphamide-induced premature ovarian failure.
    Han M, Cheng H, Wang J, Yu Y, Wang F, Zhu R, Wang W, Yang S, Li H. Gynecol Endocrinol. 2019 May 24:1-6. doi: 10.1080/09513590.2019.1616173.
  2. Human placenta-derived mesenchymal stem cells inhibit apoptosis of granulosa cells induced by IRE1α pathway in autoimmune POF mice.
    Li H, Zhao W, Wang L, Luo Q, Yin N, Lu X, Hou Y, Cui J, Zhang H. Cell Biol Int. 2019 May 13. doi: 10.1002/cbin.11165.
  3. A New Possibility in Fertility Preservation: the Artificial Ovary.
    Cho E, Kim YY, Noh K, Ku SY. J Tissue Eng Regen Med. 2019 May 6. doi: 10.1002/term.2870.
  4. Autoimmune hypothyroidism and intermittent ovarian failure – Case Report.
    Bartmann AK, Silveira LDF, Silva LFI, Formolo FSS, Amaral JPD, Serra HM, Frolich LCS. JBRA Assist Reprod. 2019 May 6. doi: 10.5935/1518-0557.20190015.
  5. EMAS position statement: Predictors of premature and early natural menopause.
    Mishra GD, Chung HF, Cano A, Chedraui P, Goulis DG, Lopes P, Mueck A, Rees M, Senturk LM, Simoncini T, Stevenson JC, Stute P, Tuomikoski P, Lambrinoudaki I. Maturitas. 2019 May;123:82-88. doi: 10.1016/j.maturitas.2019.03.008.
  6. Differentiation of primordial germ cells from premature ovarian insufficiency-derived induced pluripotent stem cells. Yang S, Ding S, He S, He L, Gao K, Peng S, Shuai C. Stem Cell Res Ther. 2019 May 31;10(1):156. doi: 10.1186/s13287-019-1261-6.
  7. Novel FSHR mutations in Han Chinese women with sporadic premature ovarian insufficiency.
    Liu H, Guo T, Gong Z, Yu Y, Zhang Y, Zhao S, Qin Y. Mol Cell Endocrinol. 2019 May 9:110446. doi: 10.1016/j.mce.2019.05.005.

Nisan 2019 Makale Özetleri

  1. Clinical and Genetic Investigation of Premature Ovarian Insufficiency Cases from Turkey.
    Oral E, Toksoy G, Sofiyeva N, Celik HG, Karaman B, Basaran S, Azami A, Uyguner ZO. J Gynecol Obstet Hum Reprod. 2019 Apr 23. pii: S2468-7847(18)30508-7. doi: 10.1016/j.jogoh.2019.04.007.
  2. Kuntai capsule attenuates premature ovarian failure through the PI3K/AKT/mTOR pathway.
    Zhang H, Qin F, Liu A, Sun Q, Wang Q, Li Q, Lu S, Zhang D, Lu Z. J Ethnopharmacol. 2019 Apr 19:111885. doi: 10.1016/j.jep.2019.111885.
  3. Zuogui Pills inhibit mitochondria-dependent apoptosis of follicles in a rat model of premature ovarian failure.
    Peng H, Zeng L, Zhu L, Luo S, Xu L, Zeng L, Li J, Liang Q, Geng H. J Ethnopharmacol. 2019 Apr 3;238:111855. doi: 10.1016/j.jep.2019.111855.
  4. Transplantation of umbilical cord-derived mesenchymal stem cells on a collagen scaffold improves ovarian function in a premature ovarian failure model of mice.
    Yang Y, Lei L, Wang S, Sheng X, Yan G, Xu L, Liu J, Liu M, Zhen X, Ding L, Sun H. In Vitro Cell Dev Biol Anim. 2019 Apr;55(4):302-311. doi: 10.1007/s11626-019-00337-4.
  5. Childhood experiences of parenting and age at menarche, age at menopause and duration of reproductive lifespan: Evidence from the English Longitudinal Study of Ageing.
    Demakakos P, Pashayan N, Chrousos G, Linara-Demakakou E, Mishra GD. Maturitas. 2019 Apr;122:66-72. doi: 10.1016/j.maturitas.2019.01.010.
  6. Dual oocyte retrieval and embryo transfer in the same cycle for women with premature ovarianinsufficiency.
    Hatirnaz S, Ata B, Hatırnaz E, Basbug A, Tannus S. Int J Gynaecol Obstet. 2019 Apr;145(1):23-27. doi: 10.1002/ijgo.12768.
  7. Effects of VEGF + Mesenchymal Stem Cells and Platelet-Rich Plasma on Inbred Rat OvarianFunctions in Cyclophosphamide-Induced Premature Ovarian Insufficiency Model.
    Vural B, Duruksu G, Vural F, Gorguc M, Karaoz E. Stem Cell Rev. 2019 Apr 29. doi: 10.1007/s12015-019-09892-5.
  8. Decreased effector regulatory T cells and increased activated CD4+ T cells in premature ovarian insufficiency.
    Kobayashi M, Nakashima A, Yoshino O, Yoshie M, Ushijima A, Ito M, Ono Y, Shima T, Kawamura K, Ishizuka B, Saito S. Am J Reprod Immunol. 2019 Apr 11:e13125. doi: 10.1111/aji.13125.
  9. Human Menstrual Blood-Derived Stromal Cells Promote Recovery of Premature Ovarian Insufficiency Via Regulating the ECM-Dependent FAK/AKT Signaling.
    Feng P, Li P, Tan J. Stem Cell Rev. 2019 Apr;15(2):241-255. doi: 10.1007/s12015-018-9867-0.

Mart 2019 Makale Özetleri

  1. Successful pregnancy with tripterygium glycoside-induced premature ovarian insufficiency: a case report.Yang Y, Ma XL, Zhang XH. J Int Med Res. 2019 Mar 28:300060519837834. doi: 10.1177/0300060519837834. [Epub ahead of print]
  2. Sexuality in premature ovarian insufficiency.Nappi RE, Cucinella L, Martini E, Rossi M, Tiranini L, Martella S, Bosoni D, Cassani C.Climacteric. 2019 Mar 22:1-7. doi: 10.1080/13697137.2019.1575356. [Epub ahead of print]
  3. Variation analysis of theTMEM150B gene in Chinese women with premature ovarian insufficiency.Shao T, Ke H, Liu R, Zhao S, Qin Y.Reprod Biomed Online. 2019 Mar;38(3):407-412. doi: 10.1016/j.rbmo.2018.12.009.
  4. Association between premature ovarian insufficiency, early menopause, socioeconomic status in a nationally representative sample from Korea.Lim YM, Jeong K, Lee SR, Chung HW, Lee W.Maturitas. 2019 Mar;121:22-27. doi: 10.1016/j.maturitas.2018.12.004.
  5. TP63-truncating variants cause isolated premature ovarian insufficiency.Tucker EJ, Jaillard S, Grover SR, van den Bergen J, Robevska G, Bell KM, Sadedin S, Hanna C, Dulon J, Touraine P, Sinclair AH.Hum Mutat. 2019 Mar 29. doi: 10.1002/humu.23744. [Epub ahead of print]
  6. The global prevalence of primary ovarian insufficiency and early menopause: a meta-analysis.Golezar S, Ramezani Tehrani F, Khazaei S, Ebadi A, Keshavarz Z.Climacteric. 2019 Mar 4:1-9. doi: 10.1080/13697137.2019.1574738. [Epub ahead of print]

Şubat 2019 Makale Özetleri

  1. Can Pregnancies Be Achieved in Premature Ovarian Insufficiency? Simpson JL, Ory SJ . Reprod Sci. 2019 Feb;26(2):157-158. doi: 10.1177/1933719118823597.
  2. Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230. Moore HCF, Unger JM, Phillips KA, Boyle F, Hitre E, Moseley A, Porter DJ, Francis PA, Goldstein LJ, Gomez HL, Vallejos CS, Partridge AH, Dakhil SR, Garcia AA, Gralow JR, Lombard JM, Forbes JF, Martino S, Barlow WE, Fabian CJ, Minasian LM, Meyskens FL, Gelber RD,
    Hortobagyi GN, Albain KS. J Natl Cancer Inst. 2019 Feb 1;111(2):210-213. doi: 10.1093/jnci/djy185.
  3. Natural history of ovarian function including assessment of ovarian reserve and premature ovarian failure. Lew R. Best Pract Res Clin Obstet Gynaecol. 2019 Feb;55:2-13. doi: 10.1016/j.bpobgyn.2018.05.005.
  4. Challenges of fertility preservation in non-oncological diseases. Condorelli M, Demeestere I. Acta Obstet Gynecol Scand. 2019 Feb 16. doi: 10.1111/aogs.13577.

Ocak 2019 Makale Özetleri

  1. Umbilical Cord Blood Mesenchymal Stem Cells as an Infertility Treatment for Chemotherapy Induced Premature Ovarian Insufficiency.
    Mohamed SA, Shalaby S, Brakta S, Elam L, Elsharoud A, Al-Hendy A. Biomedicines. 2019 Jan 18;7(1). pii: E7. doi: 10.3390/biomedicines7010007.
  2. Determination of the effects of bone marrow derived mesenchymal stem cells and ovarianstromal stem cells on follicular maturation in cyclophosphamide induced ovarian failure in rats.
    Besikcioglu HE, Sarıbas GS, Ozogul C, Tiryaki M, Kilic S, Pınarlı FA, Gulbahar O. Taiwan J Obstet Gynecol. 2019 Jan;58(1):53-59. doi: 10.1016/j.tjog.2018.11.010.
  3. Whole-exome sequencing reveals SALL4 variants in premature ovarian insufficiency: an update on genotype-phenotype correlations.
    Wang Q, Li D, Cai B, Chen Q, Li C, Wu Y, Jin L, Wang X, Zhang X, Zhang F. Hum Genet. 2019 Jan 2. doi: 10.1007/s00439-018-1962-4. [Epub ahead of print]
  4. Dual oocyte retrieval and embryo transfer in the same cycle for women with premature ovarian insufficiency.
    Hatirnaz S, Ata B, Hatırnaz E, Basbug A, Tannus S. Int J Gynaecol Obstet. 2019 Jan 28. doi: 10.1002/ijgo.12768. [Epub ahead of print]
  5. Human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation improves ovarianfunction in rats with premature ovarian insufficiency (POI)
    at least partly through a paracrine mechanism.
    Ling L, Feng X, Wei T, Wang Y, Wang Y, Wang Z, Tang D, Luo Y, Xiong Z. Stem Cell Res Ther. 2019 Jan 25;10(1):46. doi: 10.1186/s13287-019-1136-x.
  6. Ovarian tissue cryopreservation for patients with premature ovary insufficiency caused by cancer treatment: optimal protocol.
    Li Y, Ruan X, Liebenthron J, Montag M, Zhou Q, Kong W, Du J, Jin F, Li S, Cheng J, Wang H, Mueck AO1. Climacteric. 2019 Jan 24:1-7. doi: 10.1080/13697137.2018.1554644. [Epub ahead of print]
  7. A Prospective Study of Dairy-Food Intake and Early Menopause.
    Purdue-Smithe AC, Whitcomb BW, Manson JE, Hankinson SE, Rosner BA, Troy LM, Bertone-Johnson ER. Am J Epidemiol. 2019 Jan 1;188(1):188-196. doi: 10.1093/aje/kwy212.

Aralık 2018 Makale Özetleri

  1. The effects of human menstrual blood stem cells-derived granulosa cells on ovarian follicle formation in a rat model of premature ovarian failure.
    Manshadi MD, Navid S, Hoshino Y, Daneshi E, Noory P, Abbasi M. Microsc Res Tech. 2018 Dec 23. doi: 10.1002/jemt.23120. [Epub ahead of print]
  2. Ovarian function, fertility, and menopause occurrence after fertility-sparing surgery and chemotherapy for ovarian neoplasms.
    Ceppi L, Galli F, Lamanna M, Magni S, Dell’Orto F, Verri D, Delle Marchette M, Lissoni AA, Sina F, Giuliani D, Grassi T, Landoni F, Bonazzi CM, Fruscio R. Gynecol Oncol. 2018 Dec 18. pii: S0090-8258(18)31452-5. doi: 10.1016/j.ygyno.2018.11.032. [Epub ahead of print]
  3. Autologous Platelet-Rich Plasma Treatment Enables Pregnancy for a Woman in Premature Menopause.
    Sfakianoudis K, Simopoulou M, Nitsos N, Rapani A, Pappas A, Pantou A, Chronopoulou M, Deligeoroglou E, Koutsilieris M, Pantos K. J Clin Med. 2018 Dec 20;8(1). pii: E1. doi: 10.3390/jcm8010001.
  4. Long non-coding RNA HOTAIR overexpression improves premature ovarian failure by upregulating Notch-1 expression.
    Zhao W, Dong L. Exp Ther Med. 2018 Dec;16(6):4791-4795. doi: 10.3892/etm.2018.6750.
  5. Electro-acupuncture attenuates the mice premature ovarian failure via mediating PI3K/AKT/mTOR pathway.
    Zhang H, Qin F, Liu A, Sun Q, Wang Q, Xie S, Lu S, Zhang D, Lu Z. Life Sci. 2018 Dec 3. pii: S0024-3205(18)30780-X. doi: 10.1016/j.lfs.2018.11.059. [Epub ahead of print]
  6. Research on establishment of chronic stress-induced premature ovarian failure rat model and effects of Chinese medicine Munziqi treatment.
    Keremu A, Yaoliwasi A, Tuerhong M, Kadeer N, Heyi, Yiming A, Yilike X. Mol Reprod Dev. 2018 Dec 4. doi: 10.1002/mrd.23092. [Epub ahead of print]
  7. Premature Ovarian Insufficiency: Procreative Management and Preventive Strategies.
    Chae-Kim JJ, Gavrilova-Jordan L. Biomedicines. 2018 Dec 28;7(1). pii: E2. doi: 10.3390/biomedicines7010002.
  8. Identification of serum biomarkers for premature ovarian failure.
    Lee DH, Pei CZ, Song JY, Lee KJ, Yun BS, Kwack KB, Lee EI, Baek KH. Biochim Biophys Acta Proteins Proteom. 2018 Dec 28. pii: S1570-9639(18)30222-X. doi: 10.1016/j.bbapap.2018.12.007. [Epub ahead of print]
  9. Human Menstrual Blood-Derived Stromal Cells Promote Recovery of Premature OvarianInsufficiency Via Regulating the ECM-Dependent FAK/AKT Signaling.
    Feng P, Li P, Tan J. Stem Cell Rev. 2018 Dec 17. doi: 10.1007/s12015-018-9867-0. [Epub ahead of print]
  10. Resumption of Ovarian Function After Ovarian Biopsy/Scratch in Patients With PrematureOvarian Insufficiency.
    Zhang X, Han T, Yan L, Jiao X, Qin Y, Chen ZJ. Reprod Sci. 2018 Dec 12:1933719118818906. doi: 10.1177/1933719118818906. [Epub ahead of print]

Kasım 2018 Makale Özetleri

  1. Relationships between intensity, duration, cumulative dose, and timing of smoking with age at menopause: A pooled analysis of individual data from 17 observational studies
    Zhu D, Chung HF, Pandeya N, Dobson AJ, Cade JE, Greenwood DC, Crawford SL, Avis NE, Gold EB, Mitchell ES, Woods NF, Anderson D, Brown DE, Sievert LL, Brunner EJ, Kuh D, Hardy R, Hayashi K, Lee JS, Mizunuma H, Giles GG, Bruinsma F, Tillin T, Simonsen MK, Adami HO, Weiderpass E, Canonico M, Ancelin ML, Demakakos P, Mishra GD. PLoS Med. 2018 Nov 27;15(11):e1002704. doi: 10.1371/journal.pmed.1002704. eCollection 2018 Nov.
  2. Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230.
    Liu XM, Yan MQ, Ji SY, Sha QQ, Huang T, Zhao H, Liu HB, Fan HY, Chen ZJ. Cell Death Dis. 2018 Nov 19;9(12):1144. doi: 10.1038/s41419-018-1196-3.
  3. Loss of oocyte Rps26 in mice arrests oocyte growth and causes premature ovarian failure.
    Wang S, Sun M, Yu L, Wang Y, Yao Y, Wang D. Cell Physiol Biochem. 2018;50(6):2060-2070. doi: 10.1159/000495051. Epub 2018 Nov 9.
  4. Premature ovarian insufficiency may be associated with the mutations in mitochondrial tRNA genes.
    Ding Y, Xia BH, Zhuo GC, Zhang CJ, Leng JH. Endocr J. 2018 Nov 6. doi: 10.1507/endocrj.EJ18-0308.
  5. Mechanistic approach of the inhibitory effect of chrysin on inflammatory and apoptotic events implicated in radiation-induced premature ovarian failure: Emphasis on TGF-β/MAPKs signaling pathway.
    Mantawy EM, Said RS, Abdel-Aziz AK. Biomed Pharmacother. 2018 Nov 2;109:293-303. doi: 10.1016/j.biopha.2018.10.092.
  6. Investigation and treatment of premature ovarian insufficiency: A multi-disciplinary review of practice.
    Richardson A, Haridass SA, Ward E, Ayres J, Baskind NE. Post Reprod Health. 2018 Nov 4:2053369118811233. doi: 10.1177/2053369118811233.
  7. The Role of Gene Therapy in Premature Ovarian Insufficiency Management.
    Atabiekov I, Hobeika E, Sheikh U, El Andaloussi A, Al-Hendy A. Biomedicines. 2018 Nov 1;6(4). pii: E102. doi: 10.3390/biomedicines6040102.
  8. XRCC2 mutation causes premature ovarian insufficiency as well as non-obstructive azoospermia in humans.
    Zhang YX, Li HY, He WB, Tu C, Du J, Li W, Lu GX, Lin G, Yang Y, Tan YQ. Clin Genet. 2018 Nov 29. doi: 10.1111/cge.13475.
  9. Prevalence of Stress Urinary Incontinence in Women with Premature Ovarian Insufficiency.
    Tan R, Pu D, Cao J, Ge H, Chang X, Ye G, Wu J. J Womens Health (Larchmt). 2018 Nov 28. doi: 10.1089/jwh.2018.6935.
  10. Loss-of-function mutations with circadian rhythm regulator Per1/Per2 lead to premature ovarianinsufficiency.
    Zheng Y, Liu C, Li Y, Jiang H, Yang P, Tang J, Xu Y, Wang H, He Y. Biol Reprod. 2018 Nov 18. doi: 10.1093/biolre/ioy245.

Ekim 2018 Makale Özetleri

  1. Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis.
    Anagnostis P, Christou K, Artzouchaltzi AM, Gkekas NK, Kosmidou N, Siolos P, Paschou SA, Potoupnis M, Kenanidis E, Tsiridis E, Lambrinoudaki I, Stevenson JC, Goulis D. Eur J Endocrinol. 2018 Oct 1. pii: EJE-18-0602.R1. doi: 10.1530/EJE-18-0602.
  2. Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230.
    Moore HCF, Unger JM, Phillips KA, Boyle F, Hitre E, Moseley A, Porter DJ, Francis PA, Goldstein LJ, Gomez HL, Vallejos CS, Partridge AH, Dakhil SR, Garcia AA, Gralow JR, Lombard JM, Forbes JF, Martino S, Barlow WE, Fabian CJ, Minasian LM, Meyskens FL Jr, Gelber RD, Hortobagyi GN, Albain KS. J Natl Cancer Inst. 2018 Oct 27. doi: 10.1093/jnci/djy185.
  3. Postmenopausal health interventions: Time to move on from the Women’s Health Initiative?
    Thaung Zaw JJ, Howe PRC, Wong RHX. Ageing Res Rev. 2018 Oct 21;48:79-86. doi: 10.1016/j.arr.2018.10.005.
  4. Protective effects ROS up-regulation on premature ovarian failure by suppressing ROS-TERT signal pathway.
    Jiang HL, Cao LQ, Chen HY. Eur Rev Med Pharmacol Sci. 2018 Oct;22(19):6198-6204. doi: 10.26355/eurrev_201810_16025.
  5. The therapeutic potential of bone marrow mesenchymal stem cells in premature ovarian failure.
    He Y, Chen D, Yang L, Hou Q, Ma H, Xu X. Stem Cell Res Ther. 2018 Oct 4;9(1):263. doi: 10.1186/s13287-018-1008-9.
  6. Microsatellite variation of ESR1, ESR2, and AR in Serbian women with primary ovarianinsufficiency.
    Li J, Dalgleish R, Vujovic S, Dragojevic-Dikic S, Ivanisevic M, Ivovic M, Tancic M, Thompson J, Al-Azzawi F. Climacteric. 2018 Oct;21(5):472-477. doi: 10.1080/13697137.2018.1476967. Epub 2018 Aug 29.
  7. Analysis on the level of IL-6, IL-21, AMH in patients with auto-immunity premature ovarian failureand study of correlation.
    Sun S, Chen H, Zheng X, Ma C, Yue R. Exp Ther Med. 2018 Oct;16(4):3395-3398. doi: 10.3892/etm.2018.6592. Epub 2018 Aug 10.

Eylül 2018 Makale Özetleri

  1. Depletion of follicles accelerated by combined exposure to phthalates and 4-vinylcyclohexene diepoxide, leading to premature ovarian failure in rats.
    Tran DN, Jung EM, Yoo YM, Ahn C, Kang HY, Choi KC, Hyun SH, Dang VH, Pham TN, Jeung EB. Reprod Toxicol. 2018 Sep;80:60-67. doi: 10.1016/j.reprotox.2018.06.071. Epub 2018 Jun 30.
  2. Intravenous Infusion of Nucleated Peripheral Blood Cells Restores Fertility in Mice with Chemotherapy-Induced Premature Ovarian Failure. 
    El Andaloussi A, Igboeli P, Amer A, Al-Hendy A. Biomedicines. 2018 Sep 15;6(3). pii: E93. doi: 10.3390/biomedicines6030093.
  3. Heat shock pretreatment of mesenchymal stem cells for inhibiting the apoptosis of ovariangranulosa cells enhanced the repair effect on chemotherapy-induced premature ovarian failure.
    Chen X, Wang Q, Li X, Wang Q, Xie J, Fu X. Stem Cell Res Ther. 2018 Sep 26;9(1):240. doi: 10.1186/s13287-018-0964-4.
  4. ATG7 and ATG9A loss-of-function variants trigger autophagy impairment and ovarian failure.
    Delcour C, Amazit L, Patino LC, Magnin F, Fagart J, Delemer B, Young J, Laissue P, Binart N, Beau I. Genet Med. 2018 Sep 17. doi: 10.1038/s41436-018-0287-y.
  5. Recent advances in fertility preservation. 
    Dolmans MM, Manavella DD. J Obstet Gynaecol Res. 2018 Sep 23. doi: 10.1111/jog.13818.

Ağustos 2018 Makale Özetleri

  1. Exosomes derived from human adipose mesenchymal stem cells improve ovary function of premature ovarian insufficiency by targeting SMAD.
    Huang B, Lu J, Ding C, Zou Q, Wang W, Li H. Stem Cell Res Ther. 2018 Aug 9;9(1):216. doi: 10.1186/s13287-018-0953-7.
  2. Molecular Genetics of Premature Ovarian Insufficiency.
    Jiao X, Ke H, Qin Y, Chen ZJ. Trends Endocrinol Metab. 2018 Aug 2. pii: S1043-2760(18)30130-9. doi: 10.1016/j.tem.2018.07.002.
  3. Basonuclin 1 Deficiency is a Cause of Primary Ovarian Insufficiency.
    Zhang D, Liu Y, Zhang Z, Lv P, Liu Y, Li J, Wu Y, Zhang R, Huang Y, Xu G, Qian Y, Qian Y, Chen S, Xu C, Shen J, Zhu L, Chen K, Zhu B, Ye X, Mao Y, Bo X, Zhou C, Wang T, Chen D, Yang W, Tan Y, Song Y, Zhou D, Sheng J, Gao H, Zhu Y, Li M, Wu L, He L, Huang H. Hum Mol Genet. 2018 Jul 16. doi: 10.1093/hmg/ddy261.
  4. Mechanism of resveratrol in improving ovarian function in a rat model of premature ovarian insufficiency.
    Li N, Liu L. J Obstet Gynaecol Res. 2018 Aug;44(8):1431-1438. doi: 10.1111/jog.13680. Epub 2018 May 30.
  5. A randomized, double-blind, placebo-controlled trial of Chinese herbal medicine capsules for the treatment of premature ovarian insufficiency.
    Cao XJ, Huang X, Liu J, Ma F, Zeng Y, Chen C, Wang JJ, Nie G, Wang XY. Menopause. 2018 Aug;25(8):918-926. doi: 10.1097/GME.0000000000001099.
  6. Role of Trace Elements, Oxidative Stress and Immune System: a Triad in Premature Ovarian Failure.
    Verma P, K Sharma A, Shankar H, Sharma A, Rao DN. Biol Trace Elem Res. 2018 Aug;184(2):325-333. doi: 10.1007/s12011-017-1197-6. Epub 2017 Nov 27.

Temmuz 2018 Makale Özetleri

  1. Fertility Preservation: Current and Future Perspectives for Oncologic Patients at Risk for Iatrogenic Premature Ovarian Insufficiency.
    Pinelli S, Basile S. Biomed Res Int. 2018 Jul 11;2018:6465903. doi: 10.1155/2018/6465903. eCollection 2018
  2. Insulin resistance indexes in women with premature ovarian insufficiency – a pilot study.
    Kunicki M, Rudnicka E, Skórska J, Calik-Ksepka AI, Smolarczyk R. Ginekol Pol. 2018;89(7):364-369. doi: 10.5603/GP.a2018.0062.
  3. Endometrium receptivity in premature ovarian insufficiency – how to improve fertility rate and predict diseases?
    Vujović S, Ivovic M, Tančić-Gajić M, Marina L, Ljubic A, Dragojević-Dikić S, Genazzani AR. Gynecol Endocrinol. 2018 Jul 25:1-5. doi: 10.1080/09513590.2018.1490715.
  4. Serum androgen profiles in women with premature ovarian insufficiency: a systematic review and meta-analysis.
    Soman M, Huang LC, Cai WH, Xu JB, Chen JY, He RK, Ruan HC, Xu XR, Qian ZD, Zhu XM. Menopause. 2018 Jul 9. doi: 10.1097/GME.0000000000001161.
  5. A prospective study of inflammatory biomarker levels and risk of early menopause.
    Bertone-Johnson ER, Manson JE, Purdue-Smithe AC, Hankinson SE, Rosner BA, Whitcomb BW. Menopause. 2018 Jul 9. doi: 10.1097/GME.0000000000001162.

Haziran 2018 Makale Özetleri

  1. Cholesterol profile in women with premature menopause after risk reducing salpingo-oophorectomy.
    Teixeira N, Mourits MJ, Oosterwijk JC, Fakkert IE, Absalom AR, Bakker SJL, van der Meer P, de Bock GH. Fam Cancer. 2018 Jun 7. doi: 10.1007/s10689-018-0091-5.
  2. Current approaches for the treatment of premature ovarian failure with stem cell therapy.
    Sheikhansari G, Aghebati-Maleki L, Nouri M, Jadidi-Niaragh F, Yousefi M. Biomed Pharmacother. 2018 Jun;102:254-262. doi: 10.1016/j.biopha.2018.03.056. Epub 2018 Mar 22.
  3. Effects of oral contraceptives on ovulation induction in in vitro fertilization patients with premature ovarian insufficiency.
    Chen M, Han H, Chuai Y, Hao M, Shu M, Shang W. Climacteric. 2018 Jun;21(3):276-279. doi: 10.1080/13697137.2018.1439912. Epub 2018 Feb 28.
  4. Utility of complete blood count parameters to detect premature ovarian insufficiency in cases with oligomenorrhea/amenorrhea.
    Sanverdi I, Kilicci C, Cogendez E, Abide Yayla C, Ozkaya E. J Clin Lab Anal. 2018 Jun;32(5):e22372. doi: 10.1002/jcla.22372. Epub 2017 Dec 15.

Mayıs 2018 Makale Özetleri

  1. Outcomes of random start versus clomiphene citrate and gonadotropin cycles in occult premature ovarian insufficiency patients, refusing oocyte donation: a retrospective cohort study.
    Hatirnaz S, Basbug A, Akarsu S, Hatirnaz E, Demirci H, Dahan MH. Gynecol Endocrinol. 2018 May 30:1-6. doi: 10.1080/09513590.2018.1473361.
  2. Clinical research and the effect mechanism on premature ovarian failure treated with acupuncture in recent 20 years.
    Xia L, Xia Y. Zhongguo Zhen Jiu. 2018 May 12;38(5):5653-70. doi: 10.13703/j.0255-2930.2018.05.031.
  3. Is hope on the horizon for premature ovarian insufficiency?
    Bates GW Jr. Fertil Steril. 2018 May;109(5):800-801. doi: 10.1016/j.fertnstert.2018.02.129.
  4. 22q11.2 rearrangements found in women with low ovarian reserve and premature ovarian insufficiency.
    Jaillard S, Tucker EJ, Akloul L, Beaumont M, Domin M, Pasquier L, Jouve G, Odent S, Belaud-Rotureau MA, Ravel C. J Hum Genet. 2018 May;63(5):691-698. doi: 10.1038/s10038-018-0433-z. Epub 2018 Mar 14.
  5. The effect of 12-month dehydroepiandrosterone supplementation on the menstrual pattern, ovarian reserve markers, and safety profile in women with premature ovarian insufficiency.
    Wong QHY, Yeung TWY, Yung SSF, Ko JKY, Li HWR, Ng EHY. J Assist Reprod Genet. 2018 May;35(5):857-862. doi: 10.1007/s10815-018-1152-2. Epub 2018 Mar 9.

Nisan 2018 Makale Özetleri

  1. Bone marrow derived mesenchymal stem cells transplantation rescues premature ovarian insufficiency induced by chemotherapy.
    Bao R, Xu P, Wang Y, Wang J, Xiao L, Li G, Zhang C. Gynecol Endocrinol. 2018 Apr;34(4):320-326. doi: 10.1080/09513590.2017.1393661. Epub 2017 Oct 26.
  2. Successful in Vitro Fertilization and Embryo Transfer after Transplantation of Cryopreserved Ovarian Tissue: Report of the First Korean Case.
    Lee JR, Lee D, Park S, Paik EC, Kim SK, Jee BC, Suh CS, Kim SH. J Korean Med Sci. 2018 Apr 30;33(21):e156. doi: 10.3346/jkms.2018.33.e156. eCollection 2018 May 21.

Mart 2018 Makale Özetleri

  1. Nonsurgical premature menopause and reproductive implications in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.
    Levine JM, Whitton JA, Ginsberg JP, Green DM, Leisenring WM, Stovall M, Robison LL, Armstrong GT, Sklar CA. Cancer. 2018 Mar 1;124(5):1044-1052. doi: 10.1002/cncr.31121. Epub 2018 Jan 16.
  2. Estrogen treatment in infertile women with premature ovarian insufficiency in transitional phase: a retrospective analysis.
    Pinelli S, Artini PG, Basile S, Obino MER, Sergiampietri C, Giannarelli D, Simi G, Cela V. J Assist Reprod Genet. 2018 Mar;35(3):475-482. doi: 10.1007/s10815-017-1096-y. Epub 2017 Dec 5.

Şubat 2018 Makale Özetleri

  1. Influence of Sexual Function on the Social Relations and Quality of Life of Women with Premature Ovarian Insufficiency.
    Yela DA, Soares PM, Benetti-Pinto CL. Rev Bras Ginecol Obstet. 2018 Feb;40(2):66-71. doi: 10.1055/s-0037-1615289. Epub 2018 Feb 28.
  2. Premature ovarian insufficiency: why is it not being diagnosed enough in primary care?
    Newson LR, Lewis R. Br J Gen Pract. 2018 Feb;68(667):83. doi: 10.3399/bjgp18X694661.
  3. Fragile x-associated premature ovarian failure in a large Turkish cohort: Findings of Hacettepe Fragile X Registry.
    Utine GE, Şimşek-Kiper PÖ, Akgün-Doğan Ö, Ürel-Demir G, Alanay Y, Aktaş D, Boduroğlu K, Tunçbilek E, Alikaşifoğlu M. Eur J Obstet Gynecol Reprod Biol. 2018 Feb;221:76-80. doi: 10.1016/j.ejogrb.2017.12.028. Epub 2017 Dec 16.

Ocak 2018 Makale Özetleri

  1. Ocak 2018’de erken menopozla ilgili yayınlanmış çalışma yoktur.

Son Eklenenler

Sıcak basmaları daha hızlı yaşlanmanıza mı neden oluyor?
Cinsellikle ilgili şikayetlerinizin çözümü çok basit!
Menopoz sonrası sık karşılaşılan bir sorun: Pelvik organ sarkması
Büyük bir aile kurmak… Hala şansım var mı?
Hormon replasman tedavisi: Faydalar ve riskler
Erken menopoz kalp hastalığı sebebi mi?

Cinsellik ve Menopoz Prof Dr Engin Oral

ERKEN MENOPOZ